Skip to content

Prismaflex

by Gambro Renal Products, Inc.

510(k) K110823

Prismaflex is a medical device (FDA Class II; FDA product code KDI, Dialyzer, High Permeability With Or Without Sealed Dialysate System) made by Gambro Renal Products, Inc., cleared under FDA 510(k) K110823 on 17 Jun 2011, active as of 22 Oct 2026. 9 FDA recalls are linked to it.

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None ongoing

9 closed

Documents

Trust

Unverified

Source FDA 510(k), synced 22 Oct 2026.

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK110823 Date17 Jun 2011ClearedStatusActive

Official records

From the FDA record

Received by the FDA
24 Mar 2011
FDA decision
17 Jun 2011 (Substantially Equivalent)
FDA review time
85 days from receipt to decision
Public document
510(k) summary on file with the FDA

From the FDA 510(k) record K110823 (openFDA), as read on 22 Oct 2026. Quoted as published, gaps included; nothing on this list is generated.

Recalls

9 recalls · FDA

    • Terminated Z-1278-2021 FDA Class II initiated 28 Jan 2021

    Variability in the performance of the tubing in the Prismaflex Control Unit ARPS (Automatic Repositioning System) Pump Assembly, may lead to alarm situations during or after a system self-test.

  • 6 recalls, same reason

    • Terminated Z-1829-2020 FDA Class II initiated 6 Feb 2020
    • Terminated Z-1832-2020 FDA Class II initiated 6 Feb 2020
    • Terminated Z-1830-2020 FDA Class II initiated 6 Feb 2020
    • Terminated Z-1831-2020 FDA Class II initiated 6 Feb 2020
    • Terminated Z-1828-2020 FDA Class II initiated 6 Feb 2020
    • Terminated Z-1833-2020 FDA Class II initiated 6 Feb 2020

    Baxter is communicating safety information from the Prismaflex Operator's Manual regarding the proper use of connectors with the Prismaflex system.

    • Terminated Z-1923-2018 FDA Class II initiated 24 Apr 2018

    Baxter Healthcare will be installing new firmware on all Prismaflex control units to address the potential for a small number of these units to exhibit a failure mode with the pump module electronics. The failure mode may result in a Voltage Out of Range malfunction alarm, which causes the device to enter a safe state and become inoperable until it is serviced. Baxter will be releasing new firmware that will prevent the malfunction from occurring.

    • Terminated Z-1280-2018 FDA Class II initiated 15 Feb 2017

    Firm has received reports of device operators failing to adhere to instructions for use pertaining to the safe unloading of disposable sets from the Prismaflex Control Unit. Additionally, for software versions 5.10 and 6.10, the programmed syringe size for the syringe pump may revert to safe default values unintentionally.

Timeline

10 dated events

  1. Cleared FDA 510(k) K110823
  2. Recall initiated FDA recalls Z-1280-2018
  3. Recall initiated FDA recalls Z-1923-2018
  4. Recall initiated FDA recalls Z-1829-2020
  5. Recall initiated FDA recalls Z-1832-2020
  6. Recall initiated FDA recalls Z-1830-2020
  7. Recall initiated FDA recalls Z-1831-2020
  8. Recall initiated FDA recalls Z-1828-2020
  9. Recall initiated FDA recalls Z-1833-2020
  10. Recall initiated FDA recalls Z-1278-2021

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA product code
KDI
Device class
Class II
Regulation
21 CFR Part 876.5860
Advisory committee
Gastroenterology, Urology
FDA decision
SESE Substantially Equivalent

Similar devices

Other devices filed under FDA product code KDI (Dialyzer, High Permeability With Or Without Sealed Dialysate System).

Other devices from Gambro Renal Products, Inc.

See all devices from Gambro Renal Products, Inc. →